Dr. Sashi Kesavapany Ph.D is a seasoned biopharmaceutical R&D executive with over two decades of global experience leading drug discovery, translational research, and early-stage development across academia, industry, and government-linked innovation ecosystems. He has built and managed high-performance scientific organizations, directed multi-program pipelines, and driven commercialization strategies spanning target identification, preclinical validation, and Phase 1/2 clinical translation. His leadership roles at GlaxoSmithKline, NTU’s Drug Discovery Engine, SGInnovate, and Marquette University reflect a strong record of operational execution, portfolio strategy, and cross-functional team development. A former NIH Fogarty Fellow with 37 publications and active patents, Dr. Kesavapany brings a disciplined, data-driven management approach and deep domain expertise in neurodegeneration, translational biology, and biotech innovation—positioning him as a valuable contributor to boards seeking scientific rigor, strategic R&D oversight, and industry-aligned governance. His experience in military intelligence has allowed him to hone his organisational, planning and landscape knowledge and analytical skills critical in projects and programmes in science and outside science.More...